Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
Summary : First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children with early-onset MLD recently treated…